Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancerKazuya Maeda, Masahide Ohmichi, Hiroshi Sasaki et al.|Journal of Ovarian Research|2020Cited by 59
The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapyHiromi Konishi, Masahide Ohmichi, Masami Hayashi et al.|Cancer Biology & Therapy|2020Cited by 27
Patient-Derived Xenograft Models in Cervical Cancer: A Systematic ReviewTomohito Tanaka, Masahide Ohmichi, Ruri Nishie et al.|International Journal of Molecular Sciences|2021Cited by 27
MicroRNA‑22 enhances radiosensitivity in cervical cancer cell lines via direct inhibition of c‑Myc binding protein, and the subsequent reduction in hTERT expressionMayumi Nakamura, Masahide Ohmichi, Masami Hayashi et al.|Oncology Letters|2020Cited by 20
The differential expression of miRNAs between ovarian endometrioma and endometriosis-associated ovarian cancerNatsuho Nakamura, Masahide Ohmichi, Yoshito Terai et al.|Journal of Ovarian Research|2020Cited by 17